Jazz Pharmaceuticals Plc (JAZZ) |
|
Jazz Pharmaceuticals Plc Balance Sheet Quarterly
JAZZ
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
JAZZ Balance Sheets
(Quarterly, GAAP in millions $) |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
ASSETS |
Cash & cash equivalent |
1,506.31 |
1,335.69 |
1,282.30 |
1,167.91 |
881.48 |
Cash, Cash Eqvivalents Other |
- |
- |
- |
- |
- |
Cash
& Short-term Investments |
1,506.31 |
1,335.69 |
1,282.30 |
1,167.91 |
881.48 |
Accounts receivable |
705.79 |
627.84 |
610.39 |
623.94 |
651.49 |
Other Receivables |
- |
- |
- |
- |
- |
Notes Receivable, Current |
- |
- |
- |
- |
- |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization |
169.65 |
222.48 |
229.26 |
227.55 |
228.05 |
Operating Lease Right Of Use Asset |
65.34 |
65.04 |
69.04 |
75.54 |
73.33 |
Inventories |
597.04 |
611.83 |
657.21 |
674.78 |
714.06 |
Other Current Assets |
440.81 |
560.40 |
352.46 |
245.24 |
267.19 |
Prepaid Expense, Current AS |
185.48 |
109.99 |
107.49 |
72.78 |
91.91 |
Total Current Assets |
3,435.43 |
3,245.75 |
3,009.86 |
2,784.65 |
2,606.14 |
Equipment/Property/Plant Net |
- |
- |
- |
- |
- |
Goodwill net |
1,753.13 |
1,705.32 |
1,742.68 |
1,723.44 |
1,692.66 |
Intangible Assets |
5,418.04 |
5,417.86 |
5,705.78 |
5,764.21 |
5,794.44 |
Long-term investments |
- |
- |
- |
- |
- |
Accounts Receivable, Net, Noncurrent |
- |
- |
- |
- |
- |
Financial Instruments |
- |
- |
- |
- |
- |
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent |
- |
- |
- |
- |
- |
Other Assets, Noncurrent |
304.00 |
366.00 |
367.00 |
369.00 |
358.00 |
Deferred Finance Costs, Noncurrent, Net DE1 |
6.48 |
7.17 |
7.87 |
8.56 |
9.25 |
Discontinued operations, Noncurrent |
- |
- |
- |
- |
- |
Deferred Income Tax Assets Net |
477.83 |
464.37 |
430.09 |
399.10 |
376.25 |
Total Assets |
11,393.36 |
11,204.07 |
11,260.54 |
11,047.13 |
10,835.26 |
LIABILITIES |
Accounts Payable, Current AC |
102.75 |
109.85 |
98.43 |
125.45 |
90.76 |
Accrued Liabilities, Current AC |
793.91 |
769.94 |
748.30 |
712.35 |
803.26 |
Financial Instruments |
- |
- |
- |
- |
- |
Long-term Debt, Current Maturities LO |
604.95 |
604.51 |
31.00 |
31.00 |
31.00 |
Other Liabilities, Current |
- |
- |
- |
- |
- |
Taxes Payable, Current, Total |
35.07 |
89.03 |
67.53 |
40.10 |
7.72 |
Deferred Revenue, Current DE |
- |
- |
- |
- |
- |
Discontinued Operation, Liabilities, Current |
- |
- |
- |
- |
- |
Contract With Customer Liability Current |
- |
0.00 |
0.00 |
0.00 |
0.46 |
Purchased Product Rights Liability Current |
- |
- |
- |
- |
- |
Total Current Liabilities |
1,536.69 |
1,573.33 |
945.27 |
908.90 |
933.19 |
Long-term debt |
5,107.99 |
5,110.76 |
5,686.65 |
5,689.66 |
5,693.34 |
Capital Lease and Other |
- |
- |
- |
- |
- |
Long-term Debt Convertible |
- |
- |
- |
- |
- |
Total
Long-term Debt |
5,107.99 |
5,110.76 |
5,686.65 |
5,689.66 |
5,693.34 |
Financial Instruments, Insurance, Noncurrent |
- |
- |
- |
- |
- |
Employee Benefit Plans, Noncurrent |
- |
- |
- |
- |
- |
Deferred Revenue, Noncurrent DE |
- |
- |
- |
- |
- |
Deferred Tax Liabilities, Net, Noncurrent LI |
- |
- |
- |
- |
- |
Discontinued Operation, Liabilities, Noncurrent |
- |
- |
- |
- |
- |
Other liabilities, Noncurrent |
- |
- |
- |
- |
- |
Deferred Income Tax Liabilities Net |
847.71 |
841.23 |
910.72 |
932.25 |
944.34 |
Total Liabilities |
6,644.68 |
6,684.09 |
6,631.91 |
6,598.56 |
6,626.53 |
SHAREHOLDER'S EQUITY |
Nonvoting Euro Deferred Shares |
0.06 |
0.06 |
0.06 |
0.06 |
0.06 |
Capital Redemption Reserve |
0.47 |
0.47 |
0.47 |
0.47 |
0.47 |
Common Stock Value |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
Additional Paid In Capital Common Stock |
3,699.95 |
3,639.94 |
3,580.12 |
3,511.73 |
3,477.12 |
Retained Earnings / Accumulated Deficit |
878.66 |
884.30 |
811.85 |
803.01 |
733.59 |
Other Equity |
-842.15 |
-1,035.40 |
-866.82 |
-980.23 |
-1,125.51 |
Noncontrolling interests & other |
- |
- |
- |
- |
- |
Total
Stockholder's Equity |
3,737.00 |
3,489.37 |
3,525.68 |
3,335.04 |
3,085.73 |
Liabilities & Stockholder's
Equity |
11,393.36 |
11,204.07 |
11,260.54 |
11,047.13 |
10,835.26 |
|
|